These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8886811)

  • 1. Securing life through technology acceptance: the first six months after transvenous internal cardioverter defibrillator implantation.
    Burke LJ
    Heart Lung; 1996; 25(5):352-66. PubMed ID: 8886811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease-specific quality of life-patient acceptance: racial and gender differences in patients with implantable cardioverter defibrillators.
    Wilson MH; Engelke MK; Sears SF; Swanson M; Neil JA
    J Cardiovasc Nurs; 2013; 28(3):285-93. PubMed ID: 22580627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the use of subcutaneous or transvenous implantable cardioverter-defibrillators: results of the European Heart Rhythm Association prospective survey.
    Boveda S; Lenarczyk R; Fumagalli S; Tilz R; Goscinska-Bis K; Kempa M; Defaye P; Marquié C; Capucci A; Ueberham L; Dagres N
    Europace; 2018 May; 20(5):887-892. PubMed ID: 29432525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains of nursing intervention after sudden cardiac arrest and automatic internal cardioverter defibrillator implantation.
    Dougherty CM; Benoliel JQ; Bellin C
    Heart Lung; 2000; 29(2):79-86. PubMed ID: 10739483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers.
    Geiger MJ; O'Neill P; Sharma A; Skadsen A; Zimerman L; Greenfield RA; Newby KH; Wharton JM; Kent V; Natale A
    Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):624-30. PubMed ID: 9080488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living with life-saving technology - coping strategies in implantable cardioverter defibrillators recipients.
    Flemme I; Johansson I; Strömberg A
    J Clin Nurs; 2012 Feb; 21(3-4):311-21. PubMed ID: 21951323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncertainty is a major concern for patients with implantable cardioverter defibrillators.
    Flemme I; Hallberg U; Johansson I; Strömberg A
    Heart Lung; 2011; 40(5):420-8. PubMed ID: 21459446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthesia care for subcutaneous implantable cardioverter/defibrillator placement: a single-center experience.
    Essandoh MK; Portillo JG; Weiss R; Otey AJ; Zuleta-Alarcon AN; Humeidan ML; Torres JL; Flores AS; Castellon-Larios K; Abdel-Rasoul M; Andritsos MJ; Perez WJ; Stein EJ; Turner KR; Dimitrova GT; Awad H; Bhandary SP; Tripathi RS; Joseph NC; Hummel JD; Augostini RS; Kalbfleisch SJ; Tyler JD; Houmsse M; Daoud EG
    J Clin Anesth; 2016 Jun; 31():53-9. PubMed ID: 27185678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled sedation with midazolam and analgesia with nalbuphine to alleviate pain in patients undergoing subcutaneous implantable cardioverter defibrillator implantation.
    Peyrol M; Barraud J; Cautela J; Maille B; Laine M; Bonello L; Thuny F; Paganelli F; Franceschi F; Koutbi L; Levy S
    J Interv Card Electrophysiol; 2017 Aug; 49(2):191-196. PubMed ID: 28536837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter defibrillator recipients: quality of life in recipients with and without ICD shock delivery: a prospective study.
    Kamphuis HC; de Leeuw JR; Derksen R; Hauer RN; Winnubst JA
    Europace; 2003 Oct; 5(4):381-9. PubMed ID: 14753636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological reactions and family adjustment in shock versus no shock groups after implantation of internal cardioverter defibrillator.
    Dougherty CM
    Heart Lung; 1995; 24(4):281-91. PubMed ID: 7591795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transvenous pectoral implantation of single lead implantable cardioverter defibrillator.
    Wang F; Hua W; Chen X
    Chin Med J (Engl); 1999 Jan; 112(1):22-4. PubMed ID: 11593633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Internal cardioverter defibrillator device discharge: experiences of patients and family members.
    Dunbar SB; Warner CD; Purcell JA
    Heart Lung; 1993; 22(6):494-501. PubMed ID: 8288452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy).
    Pedersen SS; Mastenbroek MH; Carter N; Barr C; Neuzil P; Scholten M; Lambiase PD; Boersma L; Johansen JB; Theuns DA
    Am J Cardiol; 2016 Aug; 118(4):520-6. PubMed ID: 27353211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of technology dependency on device acceptance and quality of life in persons with implantable cardioverter defibrillators.
    Udlis KA
    J Cardiovasc Nurs; 2013; 28(6):E65-73. PubMed ID: 23348222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The subcutaneous ICD as an alternative to the conventional ICD system: Initial experience in Greece and a review of the literature.
    Sideris S; Archontakis S; Gatzoulis KA; Anastasakis A; Sotiropoulos I; Arsenos P; Kasiakogias A; Terentes D; Trachanas K; Paschalidis E; Tousoulis D; Kallikazaros I
    Hellenic J Cardiol; 2017; 58(1):4-16. PubMed ID: 28163146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.